Enhancing anti‐PD‐1 Immunotherapy by Nanomicelles Self‐Assembled from Multivalent Aptamer Drug Conjugates-Reference-Cited by-同舟云学术

Enhancing anti‐PD‐1 Immunotherapy by Nanomicelles Self‐Assembled from Multivalent Aptamer Drug Conjugates

Published:2021-06-03 Issue:28 Volume:60 Page:15459-15465
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Geng Zhongmin¹,Wang Lu¹,Liu Ke¹,Liu Jinyao¹²^ORCID,Tan Weihong¹

Affiliation:

1. Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine State Key Laboratory of Oncogenes and Related Genes Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

2. Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202102631

Reference78 articles.

2. Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy

3. Immunotherapy in colorectal cancer: rationale, challenges and potential

4. Efficient Nanovaccine Delivery in Cancer Immunotherapy

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer-controlled stimuli-responsive drug release;International Journal of Biological Macromolecules;2024-11

2. Strategic chemical synthesis and application of nanocarriers responsive to the tumor microenvironment;Nano Today;2024-10

3. Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic photothermal immunotherapy;Nature Communications;2024-06-17

4. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18

5. Developing DNA Aptamer Toolbox for Cell Research;DNA Nanotechnology for Cell Research;2024-05-03